Clinical Trial Applications: Filter, Search, and view applications
# | Protocol No | Study Title | Investigator(s) & Site(s) | |
---|---|---|---|---|
291. |
ECCT/18/12/02 | Randomized Controlled Trial to Compare the Effect of Corn-Soy Blend + Vegetable Oil 8 and Fish Oil (CSB-VO-FO) With Corn-Soy Blend + Vegetable Oil Alone (CSB-VO) on 9 the Immunological and Microbiota Patterns among Children Aged 6 to 24 months with 10 Mod Randomized Controlled Trial to Compare the Effect of Corn-Soy Blend + Vegetable Oil 8 and Fish Oil (CSB-VO-FO) With Corn-Soy Blend + Vegetable Oil Alone (CSB-VO) on 9 the Immunological and Microbiota Patterns among Children Aged 6 to 24 months with 10 Mod |
Principal Investigator(s) 1. CHRISTOPHER L. MELBY MELBY Site(s) in Kenya KENYA MEDICAL RESEARCH INSTITUTE |
View |
292. |
ECCT/18/11/02 | EPI 003 A prospective study to evaluate the safety, effectiveness and impact of the RTS,S/AS01E vaccine in young children in sub-Saharan Africa. |
Principal Investigator(s) 1. BERNHARDS OGUTU Site(s) in Kenya 1. • Ahero Clinical Trials Unit (Kisumu county) 2. KEMRI Walter Reed Army Institute of Research (Kisumu county) 3. KEMRI CDC SIAYA (Siaya county) |
View |
293. |
ECCT/18/11/01 | PrIMA PrEP Implementation for Mothers in Antenatal Care |
Principal Investigator(s) 1. Grace John-Stewart John-Stewart 2. Jared Baeten Site(s) in Kenya 1. Homa Bay County - 10 sites (Homa Bay county) 2. Siaya County - 10 sites (Siaya county) |
View |
294. |
ECCT/18/10/02 | Single-dose HPV catch-up vaccination efficacy: A blinded, randomized study of single-dose HPV vaccination among adolescent girls and young women in Kenya Single-dose HPV catch-up vaccination efficacy: A blinded, randomized study of single-dose HPV vaccination among adolescent girls and young women in Kenya |
Principal Investigator(s) 1. Dr. Nelly Rwamba Mugo 2. Dr. Maricianah Atieno Onono 3. Prof Bukusi Anne Bukusi 4. Dr. Betty Wanjiru Njoroge 5. Dr. Ruanne Barnabas Site(s) in Kenya 1. KEMRI NAIROBI (Nairobi City county) 2. KEMRI KISUMU (Kisumu county) 3. KEMRI THIKA PHRD (Kiambu county) |
View |
295. |
ECCT/18/12/01 | study to determine if a new malaria vaccine is safe and induces immunity among Kenyan adults, young children and infants. A Phase 1b, open-label, age de-escalation, dose-escalation study to evaluate the safety and immunogenicity of different doses of a candidate malaria vaccine; adjuvanted R21(R21/MM) in adults, young children and infants in Kilifi, Kenya. |
Principal Investigator(s) 1. Mainga Hamaluba Site(s) in Kenya KEMRI-Wellcome Trust Research Programme (KWTRP) Centre for Geographic Medical Research - Coast (CGMRC), Kilifi, Kenya. |
View |